Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens.

[1]  R Sanyal,et al.  Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. , 1997, Mutagenesis.

[2]  V. Mersch-Sundermann,et al.  Nitro musks are cogenotoxicants by inducing toxifying enzymes in the rat. , 1996, Mutation research.

[3]  A. Natarajan,et al.  Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe. , 1996, Mutagenesis.

[4]  H. Glatt,et al.  Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays. , 1996, Mutation research.

[5]  V. Mersch-Sundermann,et al.  A comparative study of five nitro musk compounds for genotoxicity in the SOS chromotest and Salmonella mutagenicity. , 1996, Toxicology letters.

[6]  E. Davie,et al.  Transcriptional Regulation of the Gene Coding for Human Protein C (*) , 1996, The Journal of Biological Chemistry.

[7]  R. Ulrich,et al.  Identification of dioxin-responsive genes in Hep G2 cells using differential mRNA display RT-PCR. , 1996, Biochemical and biophysical research communications.

[8]  R Sanyal,et al.  Effects of phenethyl isothiocyanate on metabolism and on genotoxicity of dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4, 5-beta]pyridine (PhIP). , 1996, Mutation research.

[9]  H. Nakajima,et al.  Enzymic sulphation of dopa and tyrosine isomers by HepG2 human hepatoma cells: stereoselectivity and stimulation by Mn2+. , 1996, The Biochemical journal.

[10]  L. Bingle,et al.  Characterization of the human surfactant protein D promoter: transcriptional regulation of SP-D gene expression by glucocorticoids. , 1996, American journal of respiratory cell and molecular biology.

[11]  C. Rompelberg,et al.  Effect of eugenol on the genotoxicity of established mutagens in the liver. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  P. Kasper,et al.  Evaluation studies on the in vitro rat hepatocyte micronucleus assay. , 1995, Mutation research.

[13]  P. Dierickx,et al.  Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities. , 1995, Mutation research.

[14]  A. Cederbaum,et al.  Increased Cytotoxicity of 3-Morpholinosydnonimine to HepG2 Cells in the Presence of Superoxide Dismutase , 1995, The Journal of Biological Chemistry.

[15]  S. Babajko.  Transcriptional regulation of insulin-like growth factor binding protein-1 expression by insulin and cyclic AMP. , 1995, Growth regulation.

[16]  K. Adeli,et al.  Human bioassays to assess environmental genotoxicity: Development of a DNA break bioassay in HepG2 cells☆ , 1995 .

[17]  S. Michel,et al.  Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium. , 1995, Carcinogenesis.

[18]  K. Adeli,et al.  Human bioassays to assess environmental genotoxicity: development of a DNA break bioassay in HepG2 cells. , 1994, Clinical biochemistry.

[19]  G. Koren,et al.  Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in vitro, is diminished by silymarin. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[20]  H. Glatt,et al.  Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells. , 1994, Mutation research.

[21]  M. Liu,et al.  De novo sulfation of L-tyrosine in HepG2 human hepatoma cells and its possible functional implication. , 1994, European journal of biochemistry.

[22]  A. Natarajan,et al.  Induction of Sister-chromatid Exchanges, Micronuclei and Gene Mutations by Indirectly Acting Promutagens Using Human Hepatoma Cells as an Activation System , 1994 .

[23]  H. Rosenkranz,et al.  Pathways for the mutagenesis of 1-nitropyrene and dinitropyrenes in the human hepatoma cell line HepG2. , 1994, Environmental health perspectives.

[24]  T. Deguchi,et al.  Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 1994, Cancer research.

[25]  T. Walle,et al.  Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells , 1994 .

[26]  L. Ferguson.  Antimutagens as cancer chemopreventive agents in the diet. , 1994, Mutation research.

[27]  C. Takahashi,et al.  Cytogenetic effects of the antichagasic benznidazole on human cells in vitro. , 1994, Mutation research.

[28]  R. Schulte‐Hermann,et al.  Effects of ethanol treatment on DNA damage induced in Escherichia coli K-12 in various organs of mice by N-nitro-sonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosopyrrolidine. , 1994, Carcinogenesis.

[29]  G Koren,et al.  In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line. , 1993, Biochemical and biophysical research communications.

[30]  A. Natarajan,et al.  The anticlastogenicity of β-carotene evaluated on human hepatoma cells , 1993 .

[31]  P. Dierickx,et al.  Metabolic activation by a supernatant from human hepatoma cells: a possible alternative in mutagenic tests. , 1993, Mutation research.

[32]  E. Sim,et al.  Arylamine N-acetyltransferase activity in human cultured cell lines. , 1993, The Biochemical journal.

[33]  C. Wolf,et al.  The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells. , 1993, Biochemical pharmacology.

[34]  R. -. Streeck,et al.  Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein , 1993, Journal of virology.

[35]  L. Poellinger,et al.  Dioxin receptor and C/EBP regulate the function of the glutathione S-transferase Ya gene xenobiotic response element , 1993, Molecular and cellular biology.

[36]  A. Pfeifer,et al.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Burk,et al.  Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis. , 1993, Virology.

[38]  Tsung-Yun Liu,et al.  Differential sensitivity of human hepatoma cell line and primary rat hepatocyte culture to benzo(a)pyrene‐induced unscheduled DNA synthesis and adduct formation. , 1993, Cell biology international.

[39]  D. Casciano,et al.  HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. , 1993, Biochemical and biophysical research communications.

[40]  T. Ohta.  Modification of genotoxicity by naturally occurring flavorings and their derivatives. , 1993, Critical reviews in toxicology.

[41]  A. Natarajan,et al.  Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro). , 1993, Mutagenesis.

[42]  D. Kardassis,et al.  Organization of the regulatory elements and nuclear activities participating in the transcription of the human apolipoprotein B gene. , 1992, The Journal of biological chemistry.

[43]  E. Roscher,et al.  Genotoxicity of 1,3- and 1,6-dinitropyrene: induction of micronuclei in a panel of mammalian test cell lines. , 1992, Mutation research.

[44]  R. Weichselbaum,et al.  Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326. , 1992, International journal of radiation oncology, biology, physics.

[45]  A. Natarajan,et al.  Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. , 1991, Mutagenesis.

[46]  S. Singh,et al.  Effect of diallyl sulfide, a naturally occurring anti-carcinogen, on glutathione-dependent detoxification enzymes of female CD-1 mouse tissues. , 1991, Biochemical pharmacology.

[47]  H. Wu,et al.  Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells , 1991, Journal of virology.

[48]  N. Loprieno,et al.  An experimental approach to identifying the genotoxic risk by cooked meat mutagens. , 1991, Advances in experimental medicine and biology.

[49]  M. Bauchinger,et al.  Induction of chromosome aberrations and sister chromatid exchange by indirectly acting mutagens in immortal mouse and rat hepatocyte lines. , 1991, Mutagenesis.

[50]  R. Pecce,et al.  Effect of enzyme inducers on metabolism of 1-nitropyrene in human hepatoma cell line HepG2. , 1991, Chemico-biological interactions.

[51]  M Ishidate,et al.  Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. , 1990, Mutation research.

[52]  A. Martelli,et al.  Human hepatocytes in genotoxicity assays. , 1990, Pharmacological research.

[53]  H. Glatt,et al.  Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing. , 1990, Molecular pharmacology.

[54]  O. Mcbride,et al.  Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. , 1990, Biochemistry.

[55]  A. Carrano,et al.  In vivo cytogenetic effects of cooked food mutagens. , 1989, Mutation research.

[56]  P. Labruzzo,et al.  Induction of aryl hydrocarbon hydroxylase and demonstration of a specific nuclear receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in two human hepatoma cell lines. , 1989, Biochemical pharmacology.

[57]  A. Bensimon,et al.  Regulatory elements controlling the basal and drug-inducible expression of glutathione S-transferase Ya subunit gene. , 1989, DNA.

[58]  G. Bárány,et al.  Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. , 1989, Cancer research.

[59]  B E Butterworth,et al.  Use of primary cultures of human hepatocytes in toxicology studies. , 1989, Cancer research.

[60]  M. Grant,et al.  The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line , 1988, FEBS letters.

[61]  S. De Flora,et al.  Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. , 1988, Mutation research.

[62]  M. Grant,et al.  Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. , 1988, Biochemical pharmacology.

[63]  M. Grant,et al.  Status of reduced glutathione in the human hepatoma cell line, HEP G2. , 1988, Biochemical pharmacology.

[64]  E. Roscher,et al.  Mutagenicity, clastogenicity and cytotoxicity of procarcinogens in a rat hepatoma cell line competent for xenobiotic metabolism. , 1988, Mutagenesis.

[65]  J. C. Ball,et al.  A preliminary study of an iron porphyrin-iodosylbenzene system for activation of mutagens in the Ames assay. , 1988, Mutation research.

[66]  R. Meschini,et al.  Induction of sister-chromatid exchanges by procarcinogens in metabolically competent Chinese hamster epithelial liver cells. , 1988, Mutation research.

[67]  G. Bárány,et al.  Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. , 1988, Carcinogenesis.

[68]  G. Michalopoulos,et al.  Induction of sister chromatid exchanges in cultured adult rat hepatocytes by directly and indirectly acting mutagens/carcinogens. , 1987, Carcinogenesis.

[69]  H. Rosenkranz,et al.  Mutagenicity, unscheduled DNA synthesis, and metabolism of 1-nitropyrene in the human hepatoma cell line HepG2. , 1987, Cancer research.

[70]  B H Margolin,et al.  Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. , 1987, Science.

[71]  H. Glatt,et al.  Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives. , 1987, Cancer research.

[72]  O. Sugita,et al.  Drug metabolism by the human hepatoma cell, Hep G2. , 1987, Biochemical and biophysical research communications.

[73]  D. Casciano,et al.  Use of the human liver cell line Hep G2 in a modified Salmonella reversion assay. , 1986, Cancer letters.

[74]  J. Williams,et al.  Induction of sister chromatid exchanges in human and rat hepatoma cell lines by cyclophosphamide and phosphoramide mustard and the effects of cytochrome P-450 inhibitors. , 1986, Biochemical pharmacology.

[75]  N. Ikekawa,et al.  Detection of natural bio-antimutagens and in vivo and in vitro analysis of their action. , 1986, Progress in clinical and biological research.

[76]  E. Gocke,et al.  Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice. , 1985, Mutation research.

[77]  J. DiGiovanni,et al.  Comparison of the metabolic activation of 7, 12-dimethylbenz(a)anthracene by a human hepatoma cell line (HepG2) and low passage hamster embryo cells. , 1984, Cancer research.

[78]  J. DiGiovanni,et al.  Mutagenic activity of methyl- and fluoro-substituted derivatives of polycyclic aromatic hydrocarbons in a human hepatoma (HepG2) cell-mediated assay. , 1984, Mutation research.

[79]  G. Williams,et al.  Differences in responses of 4 adult rat-liver epithelial cell lines to a spectrum of chemical mutagens. , 1984, Mutation research.

[80]  K. Lindahl-Kiessling,et al.  Frequency of sister chromatid exchanges in human lymphocytes cultivated with a human hepatoma cell line as an indicator of the carcinogenic potency of two cyclopenta[a]phenanthrenes. , 1984, Carcinogenesis.

[81]  R. Bos,et al.  Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assays. A comparative study with some known genotoxic compounds. , 1983, Mutation research.

[82]  R. Dean,et al.  Activation of polycyclic hydrocarbons in Reuber H4-II-E hepatoma cells. An in vitro system for the induction of SCEs. , 1983, Mutation research.

[83]  S. Limbosch.  Benzo[a]pyrene- and aldrin-metabolizing activities in cultured human and rat hepatoma cell lines. , 1983, Journal of the National Cancer Institute.

[84]  B. Ames,et al.  Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.

[85]  J. Williams,et al.  Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. , 1983, Mutation research.

[86]  J. DiGiovanni,et al.  Mutagenesis in Chinese hamster cells by cyclopenta(a)phenanthrenes activated by a human hepatoma cell line. , 1983, Cancer research.

[87]  J. R. McLain,et al.  Isolation, culture, and transplantation of human hepatocytes. , 1982, Journal of the National Cancer Institute.

[88]  L. Wattenberg,et al.  Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. , 1982, Journal of the National Cancer Institute.

[89]  G. Williams,et al.  Sister-chromatid exchange induction by polycyclic aromatic hydrocarbons in an intact cell system of adult rat-liver epithelial cells. , 1981, Mutation research.

[90]  M. Lipkin,et al.  Inhibition of Tumor Induction and Development , 1981 .

[91]  L. Wattenberg,et al.  Inhibition of Chemical Carcinogenesis by Phenols, Coumarins, Aromatic Isothiocyanates, Flavones, and Indoles , 1981 .

[92]  E. Schneider,et al.  Sister-chromatid exchange induction by carcinogens in HTC cells: an in vitro system which does not require addition of activating factors. , 1980, Mutation research.

[93]  W. Baird,et al.  Metabolic activation of benzo[a]pyrene by a human hepatoma cell line. , 1980, Carcinogenesis.

[94]  A. Dipple,et al.  Limitations of metabolic activation systems used with in vitro tests for carcinogens. , 1980, Science.

[95]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[96]  L. Sultatos,et al.  Enhanced drug-metabolizing capacity within liver adjacent to human and rat liver tumors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.

[98]  J. Selkirk.  Divergence of metabolic activation systems for short-term mutagenesis assays , 1977, Nature.

[99]  T. Sugimura,et al.  Mutagenicities of N-nitrosamines on Salmonella. , 1977, Mutation research.

[100]  G. Ficsor,et al.  Mammalian host- and fluid-mediated mutagenicity assays of captan and streptozotocin in Salmonella typhimurium. , 1977, Mutation research.

[101]  E. Farber,et al.  A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. , 1976, Cancer research.

[102]  G. Michalopoulos,et al.  Maintenance of microsomal cytochromes b5 and P-450 in primary cultures of parenchymal liver cells on collagen membranes. , 1976, Life sciences.

[103]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[104]  E. Gebhart.  Antimutagens. Data and problems. , 1974, Humangenetik.